Microbix Biosystems Inc T.MBX

There is no way…

[mercedesman]

...to paint Q4 as a positive. 

Sales YoY down, margin down, etc. 

New capacity and orders in progress are not reflected unfortunately. 

The best thing they can do is to release Q1 ASAP ( assuming a post year-end uptick for the Qtr ending Dec 2022) 
and or announce any significant orders/ contracts ( eg QAPs, STD, provincial Govts for VTMs, etc ).  If last year is a guide q1 will be released in early Feb. 

Calendar Q1 2023 is likely to be tough on the overall markets, so that won't help things in the near term. 

Overall, the direction  for 2023  is likely to be up , but from what base? 

Stingily acquiring on weakness. 

MM

[Mbxwatcher]

100 % I really felt that Cameron did everything he could to telegraph this result in the last webcast with Adelaide Capital, so in fact it is entirely unsurprising today. The only real surprise is VTM being absolutely zero in the quarter. Honestly, 9 months ago did anyone see that coming? They knew it was bad enough to tease Kinlytic,  AGAIN QAPS and Antigen are both headed in the right

[wizzdumb]

They are looking at new formulations for VTM and I assume the province is just still working through its inventory. They could issue a new big PO tomorrow for all we know. Yes they have automated line in a dedicated building but in worst case it can be retooled to QAPs which I suspect they might be doing to some extent hence no talk on fourth building for QAP expansion recently. Read Cameron's

[Mbxwatcher]

Tease comment was unfair....just been hearing it for a while